Skip to main navigation Skip to search Skip to main content

Recent Findings from Seoul National University Provides New Insights into Cancer [A Phase Ii Study of Osimertinib In Patients With Nsclc Harboring Egfr Exon 20 Insertion: a Multicenter Trial of the Korean Cancer Study Group (Lu17-19)2 2]

Press/Media

Period2024.11.12

Media coverage

1

Media coverage

  • TitleRecent Findings from Seoul National University Provides New Insights into Cancer [A Phase Ii Study of Osimertinib In Patients With Nsclc Harboring Egfr Exon 20 Insertion: a Multicenter Trial of the Korean Cancer Study Group (Lu17-19)2 2]
    Media name/outletSouth Korea Daily Report
    Country/TerritoryUnited States
    Date24.11.12
    PersonsJung-Mu Kim